Valuation: Precision System Science Co., Ltd.

Market Cap 5.96B 37.72M 33.65M 31.35M 28.53M 53.72M 3.63B 54.12M 379M 147M 1.85B 142M 139M P/E 2025
-21.7x
P/E 2026 13.5x
Enterprise Value 5.62B 35.56M 31.72M 29.55M 26.89M 50.65M 3.42B 51.02M 357M 139M 1.75B 133M 131M EV / Sales 2025
1.06x
EV / Sales 2026 0.96x
Free-Float
73.08%
Yield 2025 *
-
Yield 2026 -
07/03/25 Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on March 6, 2025. CI
07/03/25 Precision System Science Co., Ltd.'s Equity Buyback announced on March 6, 2025 has closed with 440,600 shares, representing 1.59% for ¥100.46 million. CI
06/03/25 Precision System Science Co., Ltd. announces an Equity Buyback for 440,600 shares, for ¥100.46 million. CI
06/03/25 Precision System Science Co., Ltd. authorizes a Buyback Plan. CI
01/01/25 Shuji Tajima completed the acquisition of Universal Bio Research Co., Ltd from Precision System Science Co., Ltd.. CI
14/08/24 Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. for ¥60 million. CI
18/09/23 Precision System Science Co., Ltd.(TSE:7707) dropped from S&P Global BMI Index CI
15/05/23 Precision System Science Co., Ltd. Reports Earnings Results for the Nine Months Ended March 31, 2023 CI
15/10/21 Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on August 13, 2021. CI
15/10/21 Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on August 13, 2021. CI
14/10/21 Precision System Science Co., Ltd.'s Equity Buyback announced on August 13, 2021 has expired with 152,100 shares for ¥99.97 million. CI
13/08/21 Precision System Science Co., Ltd. announces an Equity Buyback for 200,000 shares, representing 0.72% for ¥100 million. CI
13/08/21 Precision System Science Co., Ltd. authorizes a Buyback Plan. CI
Manager TitleAgeSince
President 40 01/09/2024
Corporate Officer/Principal 46 25/09/2026
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 55 30/09/2020
Director/Board Member 40 30/09/2024
Director/Board Member 46 30/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
+199.09%-.--% - - 37.72M
+3.35%-0.27%+24.56%+35.89% 250B
+3.34%-2.69%+2.89%+2.00% 156B
+3.71%-2.00%-10.14%+40.12% 144B
-0.47%-3.88%-56.43%-17.96% 61.45B
+2.44%+0.46%+13.18%+20.82% 50.28B
+1.38%-1.42%-21.15%-19.69% 46.73B
+2.09%-2.24%+20.93%+55.22% 48.29B
+3.70%+1.25%-4.33%+40.74% 45.89B
+3.51%-0.64%+34.02%+65.46% 43.24B
Average +21.91%-2.32%+0.39%+24.73% 93.91B
Weighted average by Cap. +2.77%-2.77%+4.29%+25.37%

Financials

2025 2026
Net sales 4.69B 29.7M 26.49M 24.68M 22.46M 42.3M 2.86B 42.61M 298M 116M 1.46B 111M 109M 5.22B 33.01M 29.45M 27.44M 24.97M 47.02M 3.18B 47.37M 332M 129M 1.62B 124M 121M
Net income -253M -1.6M -1.43M -1.33M -1.21M -2.28M -154M -2.3M -16.08M -6.26M -78.71M -6.01M -5.88M 394M 2.49M 2.22M 2.07M 1.89M 3.55M 240M 3.58M 25.04M 9.74M 123M 9.36M 9.16M
Net Debt -472M -2.99M -2.67M -2.48M -2.26M -4.26M -288M -4.29M -30M -11.67M -147M -11.21M -10.97M -341M -2.16M -1.93M -1.79M -1.63M -3.07M -208M -3.1M -21.67M -8.43M -106M -8.1M -7.93M
Logo Precision System Science Co., Ltd.
Precision System Science Co., Ltd. is engaged in the development, manufacture and sales of various devices for lab (laboratory) automation and clinical diagnosis. The equipment business provides various automated equipment for lab such as deoxyribonucleic acid (DNA) automatic extractors and others, immunochemical luminescence measuring devices, specimen pretreatment devices for clinical diagnosis, and fully automated gene diagnostic equipment, among others. The reagents and consumables business provide various reagents used for DNA extraction and protein purification, as well as dedicated plastic consumables such as reaction vessel and others. The maintenance-related segment is engaged in equipment maintenance business, and the sales of spare parts (replacement parts). The contract manufacturing business is engaged in the contract manufacturing business.
Employees
129